IRCT20181207041873N3
Not yet recruiting
未知
Comparison of the effect of vaginal misoprostol and evening primrose oil capsules with misoprostol alone on the consequences of abortion in women with intrauterine fetal death
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- the consequences of abortion in women with intrauterine fetal death.
- Sponsor
- Iran University of Medical Sciences
- Enrollment
- 84
- Status
- Not yet recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Iranian nationality
- •Older and equal to 18 years
- •Gestational age 12 to 20 weeks
- •Having a single fetus according to ultrasound confirmation
- •Initial bishop score less than four
- •BMI less than 30
- •Indication of termination of pregnancy due to intrauterine death of the fetus with confirmation two ultrasounds
Exclusion Criteria
- •Drugs abuse
- •smoking more than ten cigarettes a day
- •History of cesarean section
- •Contraindications to the use of evening primrose include: history of mental illness with phenothiazine, history of epilepsy, schizophrenia, history of bleeding disorders and use of anticoagulants
- •Medical disorders in the mother such as heart disease, lung disease, active liver disease, acute hepatitis
- •Previously known drug allergies to misoprostol include drowsiness, tremors, seizures, shortness of breath, hypotension, and bradycardia (WWW.Drugs.com)
- •Medicinal allergies to evening primrose, including urticaria, wheezing, facial edema, lips, tongue and throat (WWW.Drugs.com)
- •Severe anemia
- •Having cervical anomalies
- •Evening capsule vaginal capsule for two weeks continuous
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Comparison the effect of vaginal Misoprostol and vaginal Isoniazid for cervical ripening prior to hysteroscopy proceduresAbnormal uterine and vaginal bleeding, unspecified.Abnormal uterine and vaginal bleeding, unspecifiedIRCT2015112821506N4Iran University of Medical Sciences100
Completed
Phase 2
Comparison of the Effect of Vaginal misoprostol with Oxytocin for the management pregnancy terminations with IUFDIRCT20181218042033N2Bandare-abbas University of Medical Sciences106
Recruiting
Phase 3
The Effect of Laminaria with Vaginal Misoprostol on Cervical Preparation in Induction of Second Trimester AbortioIRCT20190529043759N1Zahedan University of Medical Sciences90
Recruiting
Phase 3
Comparison of the effect of vaginal misoprostol and Evening primrose Capsule on the state of deliveryormal Vaginal Delivery.IRCT20210113050028N2Ardabil University of Medical Sciences30
Completed
Not Applicable
A comparison of vaginal misoprostol versus vaginal misoprostol and nitric oxide donor for termination of pregnancy at 13 to 29 weeks. A prospective randomised trialISRCTN44341343Farhat Hached University Teaching Hospital (Tunisia)70